牛牛AI助理已提取核心訊息
Moderna, Inc. officer Stephen Hoge is set to sell 309 shares of the company's common stock on 03/04/2024, with an aggregate market value of $29,150.53. The shares were acquired on 03/01/2024 as part of a restricted stock vesting and are part of Hoge's compensation from the issuer. This transaction follows a series of sales over the past three months, where a total of 88,543 shares were sold for gross proceeds of $8,772,395.18.
Moderna, Inc. officer Stephen Hoge is set to sell 309 shares of the company's common stock on 03/04/2024, with an aggregate market value of $29,150.53. The shares were acquired on 03/01/2024 as part of a restricted stock vesting and are part of Hoge's compensation from the issuer. This transaction follows a series of sales over the past three months, where a total of 88,543 shares were sold for gross proceeds of $8,772,395.18.
Moderna, Inc.高管斯蒂芬·霍格定於2024年4月3日出售該公司的309股普通股，總市值爲29,150.53美元。這些股票於2024年3月1日作爲限制性股票歸屬的一部分收購，是Hoge從發行人那裏獲得的薪酬的一部分。該交易是在過去三個月進行的一系列銷售之後進行的，共出售了88,543股股票，總收益爲8,772,395.18美元。
Moderna, Inc.高管斯蒂芬·霍格定於2024年4月3日出售該公司的309股普通股，總市值爲29,150.53美元。這些股票於2024年3月1日作爲限制性股票歸屬的一部分收購，是Hoge從發行人那裏獲得的薪酬的一部分。該交易是在過去三個月進行的一系列銷售之後進行的，共出售了88,543股股票，總收益爲8,772,395.18美元。
有用
沒用